Training and quality assurance for rectal cancer: 20 years of data is enough

Lancet Oncology

Volumn 4, Issue 11, 2003, Pages 695-702

  Quirke, Phil ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; DIAGNOSTIC ACCURACY; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUALITY CONTROL; QUALITY OF LIFE; RECTUM CANCER; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; SURGICAL APPROACH; SURGICAL TECHNIQUE; SURGICAL TRAINING;

EID: 0242522970     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(03)01248-8     Document Type: Review

References (72)

1. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2000: Cancer incidence, mortality and prevalence worldwide, Version 1.0. IARC cancerbase No 5. Lyon: IARC, 2001 http://www-dep.iarc.fr, accessed October 2003.
2. Boyle P, Leon ML. Epidemiology of colorectal cancer. Br Med Bull 2002; 64: 1-25.
3. Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery-the clue to pelvic recurrence? Br J Surg 1982; 69: 613-16.
4. Heald RJ, Ryall RDH. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986; 1: 1479-82.
5. Heald RJ, Karanjia ND. Results of radical surgery for rectal cancer. World J Surg 1992; 16: 848-57.
6. MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet 1993; 341: 457-60.
7. Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma is caused by inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 1986; 2: 996-99.
8. Enker WE, Thaler HT, Cranor ML, et al. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 1995; 181: 335-46.
9. Enker WE, Havenga K, Thaler HT, et al. Total mesorectal excision with pelvic autonomic nerve preservation in operative treatment of rectal carcinoma. In: Soreide O, Norstein J (Eds). Rectal cancer surgery: optimisation, standardisation, documentation. Berlin: Springer, 1997; 220-43.
10. Arbman G, Nilsson E, Hallbook O, Siodahl R. Local recurrence following total mesorectal excision for rectal cancer. Br J Surg 1996;83:375-79.
11. Wibe A, Moller B, Norstein J, et al. Norwegian Rectal Cancer Group. A national strategic change in treatment policy for rectal cancer - implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum 2002; 45: 857-66.
12. Martling AL, Holm T, Rutqvist LE, et al. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Lancet 2000; 356: 93-96.
13. Kapiteijn E, Marijnen CAM, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345: 638-46.
14. Phillips RK, Hittinger R, Blesovsky L, et al. Local recurrence following 'curative' surgery for large bowel cancer: I. The overall picture. Br J Surg 1984; 71: 12-16.
15. McCall JL, Cox MR, Wattchow DA. Analysis of local recurrence rates after surgery alone for rectal cancer. Int J Colorectal Dis 1995; 10: 126-32
16. Norstein J, Langmark F. Results of rectal cancer treatment: a national experience. In: Soreide O, Norstein J (Eds). Rectal cancer surgery: optimisation, standardisation, documentation. Berlin: Springer Verlag, 1997: 17-28.
17. Kapiteijn E, Marijnen CAM, Colenbrander AC, et al. Local recurrence in patients with rectal cancer diagnosed between 1988 and 1992: a population based study in the west Netherlands. Eur J Surg Oncol 1998; 24: 528-35.
18. Mella J, Biffin A, Radcliffe AG, et al. Population-based audit of colorectal cancer management in two UK health regions. Colorectal Cancer Working Group, Royal College of Surgeons of England Clinical Epidemiology and Audit Unit. Br J Surg 1997; 84: 1731-36.
19. Hermanek P, Hermanek PJ. Role of the surgeon as a variable in the treatment of rectal cancer. Semin Surg Oncol 2000; 19: 329-35.
20. Birbeck KF, Macklin CP, Tiffin NJ, et al. Rates of circumferential margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg 2002; 235: 449-57.
21. Heald RJ, Smedh RK, Kald A, et al. Abdominoperineal excision of the rectum-an endangered operation. Norman Nigro Lectureship. Dis Colon Rectum 1997; 40: 747-51.
22. Corman ML, Allison SI, Kuehne JP (Eds). Handbook of colon and rectal surgery. London: Lippincott, Williams, and Wilkins, 2002.
23. Quirke P. Limitations of existing systems of staging for rectal cancer. In: Soreide O, Norstein J (Eds). Rectal cancer surgery: optimisation, standardisation, and documentation. Berlin: Springer Verlag, 1997: 63-8132.
24. Sterk P, Kasperk R, Opitz T, et al. Vascular organization in the mesorectum: angiography of rectal resection specimens. Int J Colorectal Dis 2000; 15: 225-28.
25. Hohenberger W, Schick CH, Gohl J. Mesorectal lymph node dissection: is it beneficial? Langenbecks Arch Surg 1998; 383: 402-08.
26. Scott N, Jackson P, Al-Jaberi T, et al. Total mesorectal excision and local recurrence: a study of tumour spread in the mesorectum distal to rectal cancer. Br J Surg 1995; 82: 1031-33.
27. Nesbakken A, Nygaard K, Westerheim O, et al. Local recurrence after mesorectal excision for rectal cancer. Eur J Surg Oncol 2002; 28: 126-34.
28. Hida J, Yasutomi M, Maruyama T, et al. Lymph node metastases detected in the mesorectum distal to carcinoma of the rectum by the clearing method: justification of total mesorectal excision. J Am Coll Surg 1997; 184: 584-88.
29. Williams NS, Dixon MF, Johnson D. Reappraisal of the 5 centimetre rule of distal excision for carcinoma: a study of distal intramural spread and patient survival. Br J Surgery 1983; 70: 150-54.
30. Karanjia ND, Schache DJ, North WR, Heald RJ. Close shave in anterior resection. Br J Surg 1990; 77: 510-12.
31. Moore HG, Riedel E, Minsky BD, et al. Adequacy of 1 cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapy. Ann Surg Oncol 2003; 10: 80-85.
32. Nagetaal ID, van de Velde CJH, van der Worp, E et al and the pathology review committee for the cooperative clinical investigators of the Dutch colorectal group. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol 2002; 20: 1729-34.
33. Tei TM, Stolzenburg T, Buntzen S, et al. Use of transpelvic rectus abdominis musculocurtaneous flap for anal cancer salvage surgery. Br J Surg 2003; 90: 575-80.
34. Martling A, Cedermark B, Johansson H, et al. The surgeon as a prognostic factor after the introduction of total mesorectal excision in the treatment of rectal cancer. Br J Surg 2002; 89: 946-47.
35. Murry M, Enker WE, Martz J. Current status of total mesorectal excision and autonomic nerve preservation in rectal cancer. Semin Surg Oncol 2000; 19: 321-28.
36. Chan KW, Boey J, Wong SKC. A method of reporting radial invasion and surgical clearance of rectal carcinoma. Histopathology 1985; 9: 1319-27.
37. Ng IO, Luk IS, Yuen ST, et al. Surgical lateral clearance in resected rectal carcinomas. A multivariate analysis of clinicopathological features. Cancer 1993; 71: 1972-76.
38. Adam IJ, Mohamdee MO, Martin IG, et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 1994; 344: 707-11.
39. de Haas-Koch DF, Baeten CGMI, Jager JJ, et al. Prognostic significance of radial margins of clearance in rectal carcinoma. Br J Surg 1996; 83: 781-85.
40. Wibe A, Rendedal PR, Svensson E, et al on behalf of the Norwegian Rectal Cancer Group. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg 2002; 89: 327-34.
41. Nagetaal ID, Marijnen CAM, Kranenbarg EK, et al. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma. Not one millimetre but two millimetres is the limit. Am J Surg Pathol 2002; 26: 350-57.
42. Nagtegaal ID. Pathological aspects of rectal carcinoma. Studies from the RT +TME trial. PhD thesis, University of Nijmegen, 2002.
43. Colorectal Cancer Working Party. CR07: pathology guided treatment in rectal cancer: a randomised trial comparing preoperative radiotherapy and selective postoperative chemoradiotherapy in rectal cancer. Clinical protocol. Medical Research Council.
44. Quirke P, Guillou P, Brown J, et al. Pathology endpoints in the MRC CLASICC trial suggest laparoscopic surgery is clinically safe. Initial results from a United Kingdom randomised trial of laparoscopic versus open surgery for colorectal cancer. J Pathol 2003, abstract (in press).
45. CLASSIC Randomised trial of laparoscopic surgery versus conventional open surgery in patients with colorectal cancer. Clinical protocol. Medical Research Council.
46. Carlsen E, Schlichting E, Guldvog I, et al. Effect of the introduction of total mesorectal excision for the treatment of rectal cancer. Br J Surg 1998; 85: 526-29.
47. Dahlberg M, Glimelius B, Pahlman L. Changing strategy for rectal cancer is associated with improved outcome. Br J Surg 1999; 86: 379-84.
48. Kockerling F, Reymond MA, Altendorf-Hofmann A, et al. Influence of surgery on metachronous distant metastases and survival in rectal cancer. J Clin Oncol 1998; 16: 324-29.
49. Kapiteijn E, Putter H, van de Velde CJH, and cooperative investigators of the Dutch ColoRectal Cancer Group. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in the Netherlands. Br J Surg 2002; 89: 1142-49.
50. Havenga K, Enker WE, McDermott K, et al. Male and female sexual and urinary function after total mesorectal excision with autonomic nerve preservation for carcinoma of the rectum. J Am Coll Surg 1996; 182: 495-502.
51. Maurer CA, Z'Graggen K, Renzulli P, et al. Total mesorectal excision preserves male genital function compared with conventional rectal cancer surgery. Br J Surg 2001; 88: 1501-05.
52. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 1997; 336: 980-987.
53. Hatfield P, Sebag-Montefiore D. The use of radiotherapy in rectal cancer. Scand J Surg 2003; 92: 65-73.
54. Dzik-Jurasz A, Domenig C, George M, et al. Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet 2002; 360: 307-08.
55. Maughan NJ, Quirke P. Modern management of colorectal cancer - a pathologists view. Scand J Surgery 2003; 92: 11-19.
56. Blomqvist L, Holm T, Rubio C, Hindmarsh T. Rectal tumours - MR imaging with endorectal and/or phased-array coils, and histopathological staging on giant sections. A comparative study. Acta Radiol 1997; 38: 437-44.
57. Brown G, Richards CJ, Newcombe RG, et al. Rectal carcinoma: thin-section MR imaging for staging in 28 patients. Radiology 1999; 211: 215-22.
58. Blomqvist L, Rubio CA, Holm T, et al. Rectal adenocarcinoma: assessment of tumour involvement of the lateral resection margin by MRI of resected specimens. Br J Radiol 1999; 72: 18-23.
59. Botterill ID, Blunt DM, Quirke P, et al. Evaluation of the role of pre-operative magnetic resonance imaging in the management of rectal cancer. Colorectal Dis 2001; 3: 295-303
60. Beets-Tan RG, Beets GL, Vliegen RF, et al. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 2001; 357: 497-504.
61. Brown G, Radcliffe AG, Newcombe RG, et al. Preoperative assessment of prognostic factors in rectal cancer using high resolution magnetic resonance imaging. Br J Surg 2003; 90: 355-64.
62. Pelican Cancer Foundation. The Mercury study. http://www.pelicancentre.com/researchprojects/researchprojects.html, accessed October, 2003.
63. Swanson RS, Compton CC, Stewart AK, Bland KI. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol 2003; 10: 65-71.
64. Joseph NE, Sigurdson ER, Hanlon AL, et al. Accuracy of determining nodal negativity in colorectal cancer on the basis of the number of nodes retrieved on resection. Ann Surg Oncol 2003; 10: 213-18.
65. Maughan NJ, Craigs C, Scott N, et al. Analysis of Northern & Yorkshire Cancer Registry Data 1995-2001. J Pathol 2003 (in press).
66. Quirke P, Williams GT. Minimum dataset for colorectal cancer histopathology reports. London: Royal College of Pathologists, 1998.
67. Cross SS, Feeley KM, Angel CA. The effect of four interventions on the informational content of histopathology reports of resected colorectal cancers. J Clin Pathol 1998; 51: 481-82
68. Goldberg S, Klas JV. Total mesorectal excision in the treatment of rectal cancer: a view from the USA. Semin Surg Oncol 1998; 15: 87-90
69. Zaheer S, Pemberton JH, Farouk R, et al. Surgical treatment of adenocarcinoma of the rectum. Ann Surg 1998; 227: 800-11.
70. Nelson H, Petrelli N, Carlin A, et al. National Cancer Institute Expert Panel. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 2001; 93: 583-96.
71. Compton CC, Fielding LP, Burgart LJ, et al. Prognostic factors in colorectal cancer. College of American Pathologists consensus statement 1999. Arch Pathol Lab Med 2000; 124: 979-94.
72. Compton CC. Pathologic prognostic factors in the recurrence of fectal cancer. Clin Colorectal Cancer 2002; 2: 149-60.